More private medical companies are rising as the industry is transforming from the "Made in China" model to "Created in China [more]
The new center will integrate biologics drug discovery, development, clinical manufacturing, and commercial manufacturing. [more]
Europe's biggest private biotech company raises $270 million BioNTech has already signed a $310 million deal with Roche [more]
China's import of medical products will continue to increase at a fast pace over the next 10 years, driven by strong domestic demand, according to a … [more]
Investment opportunities for China's healthcare sector lie in research and innovation, as well as mergers and acquisitions, said investors at a forum… [more]
The list of 2018 Top 100 Internationalized Chinese Pharmaceutical Companies was released [more]
China’s WuXi Biologics is at it again, announcing plans for a third new manufacturing site in less than a month. The CDMO will build this new biolog… [more]
Last year, the total value of medicines and health products exported from China reached $60.7 billion, up 9.44 percent year-on-year. [more]
CVS Health and Aetna Inc. on Sunday announced the execution of a definitive merger agreement under which CVS Health will acquire all outstanding shar… [more]
The traditional Chinese medicine (TCM) industry in China grew by 20 percent in the past year, according to the State Administration of Traditional Ch… [more]
Zai Lab Limited (“Zai Lab”) announces the closing of its U.S. initial public offering of 9,583,333 American depositary shares (“ADSs”) at a price… [more]
Premier Li Keqiang has said, “Medical reform should respond to people’s top concerns.” In the first half of 2017, several healthcare reform polici… [more]
China will boost its health-related industries and estimates the market for health services will reach 16 trillion yuan ($2.4 trillion) by 2030 [more]
On June 20, the 17th CPhI China, 12th P-MEC & InnoPack China, 5th ICSE China and NEX 2017 is staged in Shanghai New Int'l Expo Centre (SNIEC). The ex… [more]